Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension

Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension

The purpose of this this study is to investigate the clinical utility of renal denervation in the treatment of ESRD patients with refractory hypertension.

Inclusion Criteria:

• Systolic blood pressure of 160 mmHg or greater
• On 3 or more antihypertensive medications
• On dialysis for more than 6 months

Exclusion Criteria:

• Renal artery abnormalities
• Known secondary hypertension attributable to a cause other than sleep apnea
• MI, angina, CVA within 6 months
• Others